Industry Updates Category Banner

Industry Updates

This broad category includes articles concerning health insurance costs, carrier and health plan news, changing benefits technology, and surveys by the Kaiser Family Foundation and others on employee benefits.

Trump’s Broadside Against Health Insurers Is A Cautionary Tale For Industry

Insurers and drug companies facing dire threats to their bottom lines this year from President Donald Trump and Republicans in Congress had to make a choice: Stand and fight, or go to ground and cut some deals. Insurers fought in a bid to kill the threat; drugmakers cut deals to mitigate the damage. The early ...

Read More

FDA’s Plan To Boost Biosimilar Drugs Could Stall at the Patent Office

While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis, cancer, and other diseases, the U.S. patent office is making it harder for the cheaper medicines to get on the market, industry officials say. These officials were thrilled Oct. 29 when FDA Commissioner Marty Makary announced the ...

Read More

Sutter Plans Major New Bay Area Hospital. Here’s Where

Sutter Health plans to open a major new hospital in Santa Clara by 2031, the provider announced Monday. The eight-story, 850,000-square-foot facility from one of Northern California’s largest hospital systems will include 272 beds, an emergency department, intensive care unit, labor and delivery department and other services. It will be located at 2831 and 2841 ...

Read More

China’s Grip On American Medicine Cabinets Grows More Entrenched

A US congressional commission is ringing alarm bells about China's growing dominance over America's drug supply, saying it is putting the country's health in the hands of an adversarial nation.

Read More

Historic Government Shutdown Ends, Leaving ACA Subsidies In Limbo

Washington can now work to get its operations back up and running — but it will do so without Democrats securing their paramount objective: a concrete path forward to preserve enhanced tax credits for ACA plans set to expire at the end of 2025.

Read More

Republicans Need Trump For The Debate On Obamacare Credits

President Donald Trump didn’t get involved in negotiations to end the government shutdown. But he plans to get his hands dirty as his party confronts expiring Affordable Care Act subsidies, according to a White House official. With affordability top of mind for voters going into the midterms, too much is at stake for Trump to stay away again as ...

Read More

Kaiser Permanente and Hometown Health Announce Nevada Joint Venture

Kaiser Permanente has announced a new partnership with Renown Health, the parent of Hometown Health plan, to create a new health insurance plan known as Kaiser Permanente Nevada. Enrollment in the new plan is expected to begin in 2026 for employers and individuals in Northern Nevada.

Read More

CMS Unveils New Model To Bring Most-Favored Nation Pricing To Medicaid

The Trump administration is rolling out a new model that aims to bring most-favored nation pricing to the Medicaid space. The Centers for Medicare & Medicaid Services announced late Thursday the launch of the GENErating cost Reductions for U.S. Medicaid (GENEROUS) model, under which participating state Medicaid programs will be able to purchase certain drugs at ...

Read More

Shutdown Has Highlighted Washington’s Retreat From Big Ideas on Health Care

In the run-up to the 2020 election, all 20 Democratic presidential candidates promised voters they’d pursue bold changes to health care, such as a government-run insurance plan or expanding Medicare to cover every American. Fast-forward to the congressional stalemate that has closed the federal government for more than a month. Democrats, entrenched on one side of the ...

Read More

Trump Administration Reaches Drug Price Agreements With Eli Lilly, Novo Nordisk

The Trump administration on Thursday announced agreements with two leading drugmakers to reduce the prices many Americans pay for several of their most popular drugs. “Today, I’m thrilled to announce that the two world’s largest pharmaceutical manufacturers, Eli Lilly and Novo Nordisk, have agreed to offer their most popular GLP-1 weight loss drug — I ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square